\
&
Contact us
\
&
Contact us
Published on | 1 hour ago
Programmes HealthThe European Partnership ERA4Health has opened its seventh Joint Transnational Call that will fund 'Multi-country Investigator Initiated Clinical Trials in Cardiovascular, Autoimmune and Metabolic diseases' (Trials4Health).
The aims of the call are:
- to support randomised interventional multi-country Investigator-Initiated Clinical Studies that are designed as pragmatic comparative-effectiveness studies and/or drug repurposing studies.
- to encourage and enable transnational collaboration between clinical/public health research teams (from hospital/ public health, healthcare settings and other healthcare organisations) that conduct multi-country IICS, either comparative-effectiveness or drug repurposing studies.
Note that clinical studies conducted for direct commercial purposes are excluded from support by the ERA4Health programme. In the case of the involvement of any private for-profit entity, it is needed that the consortia duly justify their role in the proposal and that there is no commercial purpose or benefit.
Belgium participates in the call with KCE Trials acting as Belgian funding organisation. Find out who can submit at Belgian level and the details of the additional requirements for Belgium here.
Find out more about the call and conditions to apply on the ERA4Health dedicated webpage. Deadline for pre-proposal submission is 27 January 2026. Documents required at national level and a copy of the pre-proposal must be sent by e-mail to KCE within the same deadline (trials@kce.fgov.be).
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Avia-GIS is a Belgian innovative SME established in 2001. They have built research and public authority trust over the past 19 years and developed a unique, disruptive software suite - VECMAP® - that supports society to overcome one of its important health threats, the spreading of Pests of Public Health importance.
With the help of a Horizon 2020 SME Instrument Phase 2 project, they will be able to add Integrated Pest Management functionalities and go to the market. With the grant, that was an essential component of their second investment round, Avia-GIS aims at raising its revenue from the current 2 M€ to 14.2 M€ in 2024, and increase the headcount from 15 to 58.
